Home 2016
Archives
Nivolumab Ups Overall Survival in Head, Neck Cancer
Longer overall survival compared with single-agent therapy for platinum-refractory squamous-cell cancer
Ribociclib + Letrozole Beneficial in Advanced Breast Cancer
Longer duration of progression-free survival in patients with HR+, HER2− breast cancer
High-Flow Oxygen Not Inferior for Averting Reintubation
Not inferior to noninvasive mechanical ventilation for high-risk patients who have undergone extubation
Levosimendan Doesn’t Prevent Acute Organ Dysfunction
Drug also tied to lower odds of successful weaning from mechanical ventilation in adults with sepsis
Conservative Oxygen Treatment Linked to Lower ICU Mortality
Findings among adult ICU patients with expected length of stay of 72 hours or longer
Empirical Micafungin Treatment Doesn’t Improve Survival
No increase in invasive fungal infection-free survival for ICU-acquired sepsis, Candida colonization
Hydrocortisone Doesn’t Cut Risk of Septic Shock in Sepsis
Among adults with severe sepsis not in septic shock, no reduction in septic shock with hydrocortisone
Dupilumab Effective in Atopic Dermatitis
Primary outcome occurred significantly more often for patients receiving dupilumab in SOLO 1, SOLO 2
ASTRO: Fewer Side Effects With IMRT in Cervical, Endometrial CA
Patients in conventional radiotherapy arm had more high-level adverse events than those in IMRT arm
ASTRO: No Survival Benefit for Adding EBT to Brachytherapy
Addition of external beam therapy doesn't improve five-year progression-free survival in prostate cancer
